Metformin Prostate Cancer Adjuvant Trial
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Prostate Cancer
-
Age: Between 18 years - 100 years
-
Gender: Male
-
Other Inclusion Criteria:
1) Patients who have biopsy confirmed adenocarcinoma of the prostate. 2) Patients who have had radical prostatectomy.
You may not be eligible for this study if the following are true:
-
1) Patients who have metastatic disease and have been treated for prostate cancer with the following: chemotherapy, hormonal therapy, oral glucocorticoids, and GnRH analogues. 2) Patients who have current or previous use of the following: use of 5a-reductase inhibitors, drugs with antiandrogenic properties, diagnosis of type 1 diabetes mellitus, exposure to metformin within 12 months of screening, and planned or concurrent use of any oral or injectable diabetes drug.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.